A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
Getinge AB (publ) provides products and solutions for operating rooms, intensive-care units, and sterilization departments in Sweden and internationally. The company operates through Acute Care Therapies, Life Science, and Surgical Workflows segments. It offers extracorporeal membrane oxygenation, mechanical ventilation, advanced patient monitoring, ICU infrastructure equipment, and drainage solutions. In addition, the company provides surgical perfusion, endoscopic vessel harvesting, intra-aortic balloon counterpulsation, vascular and cardiothoracic surgery equipment, peripheral stenting, OEM solutions, and beating heart surgery equipment; and operating room equipment, anesthesia, advanced patient monitoring, and operating room integration solutions. Further, it offers pre-cleaning, cleaning and disinfection, sterilization, consumables, endoscope reprocessing, and sterile supply management solutions; connected medical devices, and patient flow management; and low temperature sterilization, biocontainment in vaccine production, terminal sterilization, sterile isolation technology, cleaning and sterilization, aseptic transfer, and large-scale cultivation. Additionally, the company provides bioreactor preparation solution, bioprocess development and optimization, labware cleaning and sterilization, biocontainment, and vivarium. It offers its products through a network of sales companies, as well as through agents and distributors in the Americas, Europe, the Middle East, Africa, and the Asia and Pacific. Getinge AB (publ) was founded in 1904 and is headquartered in Gothenburg, Sweden.
Financial Summary
| Share Statistics | GNGBY | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $6,779.6 | $337.2 | 72% |
|
| Shares Out (Mil) | 28.1 | 41.9 | 36% |
|
| Institutional Ownership | 29.4% | 77.8% | 13% |
|
| Float (Mil) | 178.5 | 34.7 | 72% |
|
| Beta | 0.80 | 0.85 | 47% |
|
| Avg Daily Volume (000s) | 1 | 278 | 4% |
|
| Price Change (52-week) |
29.3% | 58.7% | 68% |
|
| Growth | GNGBY | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 0.9% | 11.8% | 19% |
|
| Net Income (5yr) | (9.1%) | (5.8%) | 30% |
|
| EPS (5yr) | (9.1%) | 11.4% | 22 |
|
| Dividends (5yr) | 7.1% | 0.0% | 69% |
|
| Cash Flow (5yr) | (38.0%) | (16.3%) | 13% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | na | na | na | |
| Current EPS | na | na | na | |
| Month Ago EPS | na | na | na | |
| # Rev Up | na | na | na | |
| # Rev Down | na | na | na | |
| Three Months Ago EPS | na | na | na | |
| Year/Year Chg | na | na | na | |
| Financials | GNGBY | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $3,532 | $152 | 70% |
|
| Net Income (TTM) (Mil) | $276 | ($10) | 72% |
|
| EPS (TTM) | $1.014 | ($0.500) | 61% |
|
| Operating Cash Flow (TTM) (Mil) | $520 | ($2) | 72% |
|
| Net Cash Flow (TTM) (Mil) | $18 | $1 | 62% |
|
| Long-Term Debt (Q1) (Mil) | $938 | $22 | 66% |
|
| Enterprise Value (Q1) (Mil) | $7,492 | $304 | 69% |
|
| Valuation | GNGBY | Industry Median |
Percentile (All Stocks) |
|
| P/B | na | 2.80 | na |
|
| P/E | na | 31.1 | na |
|
| Dividend Yield | na | 0.0% | na |
|
| PEG (5yr hist) | na | 1.9 | na |
|
| Ratios | GNGBY | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 48.6% | 59.1% | 61% |
|
| Net Margin | 7.8% | (7.3%) | 57% |
|
| ROA | 4.7% | (13.7%) | 71% |
|
| ROE | 8.9% | (15.8%) | 54% |
|
| Liabilities to Assets | 46.0% | 44.7% | 37% |
|
| F-Score | na | 4 | na |
|
Getinge AB (publ) did not pass any screens on 7/31/2026.
